{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:23:12Z","timestamp":1782814992338,"version":"3.54.5"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Region Nordjylland"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Patients with B-cell neoplasms in remission are monitored with regular physician visits at the hospital. The current standard follow-up procedure is not evidence-based or individualized to patient needs. To improve and individualize the follow-up, we investigated the feasibility of a shared care follow-up initiative, with alternating physician visits and nurse-led telephone consultations and assessments based on patient-reported outcome (PRO) data.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients \u226518\u2009years diagnosed with B-cell neoplasms were eligible for the study when they were in remission and stable without treatment for at least 6 months. Patients were assigned to alternating visits with physicians and nurse-led telephone consultations. The nurse-led telephone consultations were based on PROs, which were collected with the European Organization for Research and Treatment of Cancer questionnaire (EORTC-QLQ-C30), the Myeloproliferative Neoplasm \u2013 Symptom Assessment Form, and the Hospital Anxiety and Depression Scale. Patients completed questionnaires before every nurse-led consultation. We also applied the Patient Feedback Form to survey patient acceptance of the requirement of questionnaire completion. We applied descriptive statistics, in terms of counts (n) and proportions (%), to describe the study population and all endpoints.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Between February 2017 and December 2018, 80 patients were enrolled. Adherence, measured as the recruitment rate, was 96% (80\/83), and the drop-out rate was 6% (5\/80). During the study period, 3\/80 (4%)\u00a0patients relapsed, and 5\/80 (6%)\u00a0patients returned to the standard follow-up, because they required closer medical observation. Relapses were diagnosed based on unscheduled visits requested by patients (<jats:italic>n<\/jats:italic>\u00a0=\u20092) and patient-reported symptoms reviewed by the nurse (<jats:italic>n<\/jats:italic>\u00a0=\u20091). The response\u00a0rate to questionnaires was 98% (335\/341). A total of 58\/79 (74%) patients completed the Patient Feedback Form; 51\/57 (89%) patients reported improved communication with health care professionals; and 50\/57 (88%) patients reported improved recollection of symptoms as a result of completing questionnaires.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Based on patient adherence, a low relapse rate, and positive patient attitudes towards completing questionnaires, we concluded that a shared care follow-up, supported by PROs, was a feasible alternative to the standard follow-up for patients with B-cell disease in remission.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-020-05899-8","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T02:02:25Z","timestamp":1605578545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Shared care follow-up of patients with B-cell neoplasms based on nurse-led telephone consultations and PRO-data: a feasibility study from the North Denmark Region"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9761-6201","authenticated-orcid":false,"given":"Mia","family":"Sommer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone","family":"Frandsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paw","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren Ramme","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars B\u00f8rty","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus Froberg","family":"Br\u00f8ndum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"B\u00f8gsted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Tang","family":"Severinsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik Elgaard","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Gr\u00f8nkj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarec Christoffer","family":"El-Galaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"5899_CR1","first-page":"v78","volume":"26","author":"B Eichhorst","year":"2015","unstructured":"Eichhorst B, Robak T, Montserrat E, Ghia P, Hillmen P, Hallek M, et al. Chronic lymphocytic leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up \u2020. ESMO Updat Clin Pract Guidel. 2015;26:v78\u201384.","journal-title":"ESMO Updat Clin Pract Guidel"},{"issue":"1","key":"5899_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","volume":"31","author":"E Zucca","year":"2020","unstructured":"Zucca E, Arcaini L, Buske C, Johnson PW, Ponzoni M, Raderer M, et al. Marginal zone lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(1):17\u201329.","journal-title":"Ann Oncol"},{"key":"5899_CR3","first-page":"v116","volume":"26","author":"H Tilly","year":"2015","unstructured":"Tilly H. Gomes Da Silva M, Vitolo U, Jack a, Meignan M, Lopez-Guillermo a, et al. diffuse large B-cell lymphoma (DLBCL): ESMO clinical practice guidelines for diagnosis, treatment and follow-up \u2020. ESMO Updat Clin Pract Guidel. 2015;26:v116\u201325.","journal-title":"ESMO Updat Clin Pract Guidel"},{"key":"5899_CR4","volume-title":"Opf\u00f8lgningsprogram for lymfeknudekr\u00e6ft og kronisk lymfatisk leuk\u00e6mi (Follow-up of lymphoma and chronic lymphatic leukemia)","author":"Sundhedsstyrelsen","year":"2015","unstructured":"Sundhedsstyrelsen. Opf\u00f8lgningsprogram for lymfeknudekr\u00e6ft og kronisk lymfatisk leuk\u00e6mi (Follow-up of lymphoma and chronic lymphatic leukemia). 2015. Available from: https:\/\/www.sst.dk\/-\/media\/Udgivelser\/2019\/Pakkeforloeb-kraeft-2015-2019\/Opf\u00f8lgningsprogrammer-for-kr\u00e6ft-2015\/Opf\u00f8lgningsprogram-for-lymfeknudekr\u00e6ft-og-kronisk-lymfatisk-leuk\u00e6mi---FINAL.ashx?la=da&hash=A502C520C59B1D807BB6E2508C341C0B4F6E69D1."},{"key":"5899_CR5","volume-title":"Danish lymphoma group: National Guidelines for treatment of diffuse large B-cell lymphoma","author":"J J\u00f8rgensen","year":"2015","unstructured":"J\u00f8rgensen, J, Madsen, J, Hansen P et al. Danish lymphoma group: National Guidelines for treatment of diffuse large B-cell lymphoma. 2015. Available from: http:\/\/www.lymphoma.dk\/wp-content\/uploads\/2016\/11\/DLBCLRekommandationer2015ver2_1.pdf."},{"key":"5899_CR6","volume-title":"Danish lymphoma group: guidelines for diagnosing, treatment and follow-up of follicular lymphoma","author":"H Bentzen","year":"2015","unstructured":"Bentzen H, Vissing K, Munksgaard L, Do T, Jensen P, Pedersen M, et al. Danish lymphoma group: guidelines for diagnosing, treatment and follow-up of follicular lymphoma. 2015. Available from: http:\/\/www.lymphoma.dk\/wp-content\/uploads\/2016\/11\/Follikul\u00c3\u00a6rt_lymfom_guidelines_2015.pdf."},{"key":"5899_CR7","volume-title":"Danish Lymphoma Group: National guidelines for treatment of chronic lymphatic leukemia","author":"I Christiansen","year":"2016","unstructured":"Christiansen, I; Pulczynski, El;Gillstr\u00f6m D et al. Danish Lymphoma Group: National guidelines for treatment of chronic lymphatic leukemia. 2016. Available from: http:\/\/www.lymphoma.dk\/retningslinjer\/."},{"key":"5899_CR8","doi-asserted-by":"crossref","unstructured":"H\u00f8eg BL, Bidstrup PE, Allerslev Horsboel T, Dalton SO, Saltbaek L, Karlsen RV, et al. Follow-up strategies following completion of primary cancer treatment in adult cancer survivors. Cochrane Database Syst Rev. 2019;11.","DOI":"10.1002\/14651858.CD012425.pub2"},{"issue":"6","key":"5899_CR9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ajh.23688","volume":"89","author":"T El-Galaly","year":"2014","unstructured":"El-Galaly T, Mylam KJ, B\u00f8gsted M, Brown P, Rossing M, Gang AO, et al. Role of routine imaging in detecting recurrent lymphoma: a review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma. Am J Hematol. 2014;89(6):575\u201380.","journal-title":"Am J Hematol"},{"key":"5899_CR10","volume-title":"Acute leukemia group Denmark: National Guidelines for treatment of acute myeloid leukemia","author":"C Sch\u00f6llkopf","year":"2015","unstructured":"Sch\u00f6llkopf, C, Weber, D, Sengel\u00f8v H et al. Acute leukemia group Denmark: National Guidelines for treatment of acute myeloid leukemia. 2015. Available from: https:\/\/hematology.dk\/index.php\/vejledninger\/kliniske\/2012-11-06-06-19-25\/43-aml\/file."},{"issue":"4","key":"5899_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.29","volume":"5","author":"P Allart-Vorelli","year":"2015","unstructured":"Allart-Vorelli P, Porro B, Baguet F, Michel A, Cousson-G\u00e9lie F. Haematological cancer and quality of life: a systematic literature review. Blood Cancer J. 2015;5(4):e305.","journal-title":"Blood Cancer J"},{"key":"5899_CR12","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s11764-020-00869-9","volume":"14","author":"J Firkins","year":"2020","unstructured":"Firkins J, Hansen L, Driessnack M, Dieckmann N. Quality of life in \u201cchronic\u201d cancer survivors: a meta-analysis. J Cancer Surviv. 2020;14:504\u201317.","journal-title":"J Cancer Surviv"},{"issue":"5","key":"5899_CR13","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1007\/s11764-018-0708-6","volume":"12","author":"H G\u00f6tze","year":"2018","unstructured":"G\u00f6tze H, Taubenheim S, Dietz A, Lordick F, Mehnert A. Comorbid conditions and health-related quality of life in long-term cancer survivors\u2014associations with demographic and medical characteristics. J Cancer Surviv. 2018;12(5):712\u201320.","journal-title":"J Cancer Surviv"},{"issue":"6","key":"5899_CR14","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/bjh.12698","volume":"164","author":"A Korszun","year":"2014","unstructured":"Korszun A, Sarker SJ, Chowdhury K, Clark C, Greaves P, Johnson R, et al. Psychosocial factors associated with impact of cancer in longterm haematological cancer survivors. Br J Haematol. 2014;164(6):790\u2013803.","journal-title":"Br J Haematol"},{"issue":"9","key":"5899_CR15","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/pon.3247","volume":"22","author":"A Hall","year":"2013","unstructured":"Hall A, Campbell HS, Sanson-Fisher R, Lynagh M, D\u2019Este C, Burkhalter R, et al. Unmet needs of Australian and Canadian haematological cancer survivors: a cross-sectional international comparative study. Psychooncology. 2013;22(9):2032\u20138.","journal-title":"Psychooncology."},{"issue":"1","key":"5899_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jgo.2018.05.011","volume":"10","author":"H G\u00f6tze","year":"2019","unstructured":"G\u00f6tze H, K\u00f6hler N, Taubenheim S, Lordick F, Mehnert A. Polypharmacy, limited activity, fatigue and insomnia are the most frequent symptoms and impairments in older hematological cancer survivors (70+): findings from a register-based study on physical and mental health. J Geriatr Oncol. 2019;10(1):55\u20139.","journal-title":"J Geriatr Oncol"},{"issue":"4","key":"5899_CR17","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00520-014-2123-5","volume":"22","author":"B Swash","year":"2014","unstructured":"Swash B, Hulbert-Williams N, Bramwell R. Unmet psychosocial needs in haematological cancer: a systematic review. Vol. 22. Support Care Cancer. 2014;22(4):1131\u201341.","journal-title":"Support Care Cancer"},{"issue":"1","key":"5899_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pec.2009.02.005","volume":"77","author":"EA Lobb","year":"2009","unstructured":"Lobb EA, Joske D, Butow P, Kristjanson LJ, Cannell P, Cull G, et al. When the safety net of treatment has been removed: patients\u2019 unmet needs at the completion of treatment for haematological malignancies. Patient Educ Couns. 2009;77(1):103\u20138.","journal-title":"Patient Educ Couns"},{"issue":"3","key":"5899_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11764-016-0591-y","volume":"11","author":"D Oberoi","year":"2017","unstructured":"Oberoi D, White V, Seymour J, Miles Prince H, Harrison S, Jefford M, et al. The course of anxiety, depression and unmet needs in survivors of diffuse large B cell lymphoma and multiple myeloma in the early survivorship period. J Cancer Surviv. 2017;11(3):329\u201338.","journal-title":"J Cancer Surviv"},{"issue":"4","key":"5899_CR20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-2648.2008.04927.x","volume":"65","author":"R Lewis","year":"2009","unstructured":"Lewis R, Neal RD, Williams NH, France B, Wilkinson C, Hendry M, et al. Nurse-led vs. conventional physician-led follow-up for patients with cancer: systematic review. J Adv Nurs. 2009;65(4):706\u201323.","journal-title":"J Adv Nurs"},{"issue":"1","key":"5899_CR21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1365-2648.2003.02672.x","volume":"43","author":"K Cox","year":"2003","unstructured":"Cox K, Wilson E. Follow-up for people with cancer: nurse-led services and telephone interventions. J Adv Nurs. 2003;43(1):51\u201361.","journal-title":"J Adv Nurs"},{"issue":"4","key":"5899_CR22","doi-asserted-by":"crossref","first-page":"E168","DOI":"10.1188\/17.ONF.E168-E184","volume":"44","author":"S-R Suh","year":"2017","unstructured":"Suh S-R, Lee MK. Effects of nurse-led telephone-based supportive interventions for patients with Cancer: a meta-analysis. Oncol Nurs Forum. 2017;44(4):E168\u201384.","journal-title":"Oncol Nurs Forum"},{"issue":"1","key":"5899_CR23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1472-6963-13-211","volume":"13","author":"J Chen","year":"2013","unstructured":"Chen J, Ou L, Hollis SJ. A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res. 2013;13(1):211.","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"5899_CR24","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1200\/JCO.2007.13.3439","volume":"26","author":"CC Gotay","year":"2008","unstructured":"Gotay CC, Kawamoto CT, Bottomley A, Efficace F. The prognostic significance of patient-reported outcomes in Cancer clinical trials. J Clin Oncol. 2008;26(8):1355\u201363.","journal-title":"J Clin Oncol"},{"issue":"6","key":"5899_CR25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom monitoring with patient-reported outcomes during routine Cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557\u201365.","journal-title":"J Clin Oncol"},{"issue":"42","key":"5899_CR26","first-page":"26","volume":"2","author":"J Greenhalgh","year":"2018","unstructured":"Greenhalgh J, Gooding K, Gibbons E, Dalkin S, Wright J, Valderas J, et al. How do patient reported outcome measures (PROMs) support clinician-patient communication and patient care? A realist synthesis. J Patient Rep Outcomes. 2018;2(42):26.","journal-title":"J Patient Rep Outcomes."},{"issue":"5","key":"5899_CR27","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1200\/JOP.2014.001413","volume":"10","author":"BF Claire Snyder","year":"2014","unstructured":"Claire Snyder BF, Herman JM, White SM, Luber BS, Blackford AL, Carducci MA, et al. When using patient-reported outcomes in clinical practice, the measure matters: a randomized controlled trial. J Oncol Pract. 2014;10(5):e299\u2013306.","journal-title":"J Oncol Pract"},{"issue":"8","key":"5899_CR28","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s11136-011-0054-x","volume":"21","author":"CF Snyder","year":"2012","unstructured":"Snyder CF, Aaronson NK, Choucair AK, Elliott TE, Greenhalgh J, Halyard MY, et al. Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations. Qual Life Res. 2012;21(8):1305\u201314.","journal-title":"Qual Life Res"},{"issue":"1","key":"5899_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11648\/j.ajtas.20160501.11","volume":"5","author":"I Etikan","year":"2016","unstructured":"Etikan I. Comparison of convenience sampling and purposive sampling. Am J Theor Appl Stat. 2016;5(1):1.","journal-title":"Am J Theor Appl Stat"},{"key":"5899_CR30","unstructured":"World Health Organization (WHO). Self-care interventions for health. Available from: https:\/\/www.who.int\/health-topics\/self-care#tab=tab_1.\u00a0Accessed 26 July 2020."},{"key":"5899_CR31","unstructured":"Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran DBA. EORTC QLQ-C30 scoring manual (3rd edition). Brussels:\u00a0European Organisation for Research and Treatment of Cancer;\u00a02001."},{"issue":"33","key":"5899_CR32","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1200\/JCO.2012.42.3863","volume":"30","author":"RM Emanuel","year":"2012","unstructured":"Emanuel RM, Dueck AC, Geyer HL, Kiladjian J-J, Slot S, Zweegman S, et al. Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs. J Clin Oncol. 2012;30(33):4098\u2013103.","journal-title":"J Clin Oncol"},{"key":"5899_CR33","volume-title":"The hospital anxiety and depression manual","author":"RP Snaith","year":"1994","unstructured":"Snaith RP, Zigmond AS. The hospital anxiety and depression manual. London: GL Assessment; 1994."},{"issue":"5","key":"5899_CR34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365\u201376.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"5899_CR35","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1182\/blood-2011-01-328955","volume":"118","author":"R Scherber","year":"2011","unstructured":"Scherber R, Dueck AC, Johansson P, Barbui T, Barosi G, Vannucchi AM, et al. The Myeloproliferative neoplasm symptom Assessment form (MPN-SAF): international prospective validation and reliability trial in 402 patients. Blood. 2011;118(2):401\u20138.","journal-title":"Blood."},{"issue":"6","key":"5899_CR36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370.","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"5899_CR37","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/BF00434800","volume":"2","author":"MA Sprangers","year":"1993","unstructured":"Sprangers MA, Cull A, Bjordal K, Groenvold M, Aaronson NK. The European Organization for Research and Treatment of Cancer. Approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC study group on quality of life. Qual Life Res. 1993;2(4):287\u201395.","journal-title":"Qual Life Res"},{"key":"5899_CR38","unstructured":"The European Organisation for Research and Treatment of Cancer. EORTC Study Tools. Available from: https:\/\/www.eortc.org\/tools\/. Accessed 30 Oct 2020."},{"key":"5899_CR39","unstructured":"GL Assessment. Hospital Anxiety and Depression Scale (HADS) A reliable self-rating scale that measures anxiety and depression. Available from: https:\/\/www.gl-assessment.co.uk\/products\/hospital-anxiety-and-depression-scale-hads\/.\u00a0Accessed 30\u00a0Oct 2020."},{"key":"5899_CR40","unstructured":"Vanderbilt. Software \u2013 REDCap . Available from: https:\/\/projectredcap.org\/software\/. Accessed 10 Feb 2020."},{"issue":"1","key":"5899_CR41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12955-018-0900-4","volume":"16","author":"LK Tolstrup","year":"2018","unstructured":"Tolstrup LK, Pappot H, Zangger G, Bastholt L, Zwisler A-D, Dieperink KB. Danish translation, cultural adaption and initial psychometric evaluation of the patient feedback form. Health Qual Life Outcomes. 2018;16(1):77.","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"5899_CR42","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/1475-6773.11194","volume":"37","author":"KM Mazor","year":"2002","unstructured":"Mazor KM, Clauser BE, Field T, Yood RA, Gurwitz JH. A demonstration of the impact of response bias on the results of patient satisfaction surveys. Health Serv Res. 2002;37(5):1403\u201317.","journal-title":"Health Serv Res"},{"key":"5899_CR43","doi-asserted-by":"crossref","unstructured":"Saltb\u00e6k L, Karlsen RV, Bidstrup PE, H\u00f8eg BL, Zoffmann V, Horsb\u00f8l TA, et al. MyHealth: specialist nurse-led follow-up in breast cancer. A randomized controlled trial \u2013 development and feasibility. Acta Oncol (Madr). 2019;58(5):619\u201326.","DOI":"10.1080\/0284186X.2018.1563717"},{"issue":"10","key":"5899_CR44","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1463-1318.2012.02936.x","volume":"14","author":"K Beaver","year":"2012","unstructured":"Beaver K, Campbell M, Williamson S, Procter D, Sheridan J, Heath J, et al. An exploratory randomized controlled trial comparing telephone and hospital follow-up after treatment for colorectal cancer. Color Dis. 2012;14(10):1201\u20139.","journal-title":"Color Dis"},{"issue":"34","key":"5899_CR45","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1200\/JCO.2015.62.0229","volume":"33","author":"TC El-Galaly","year":"2015","unstructured":"El-Galaly TC, Jakobsen LH, Hutchings M, de Nully BP, Nilsson-Ehle H, Sz\u00e9kely E, et al. Routine imaging for diffuse large B-cell lymphoma in first complete remission does not improve post-treatment survival: a Danish-Swedish population-based study. J Clin Oncol. 2015;33(34):3993\u20138.","journal-title":"J Clin Oncol"},{"issue":"3","key":"5899_CR46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/2374373517706613","volume":"4","author":"R Casey","year":"2017","unstructured":"Casey R, Powell L, Braithwaite M, Booth C, Sizer B, Corr J. Nurse-led phone call follow-up clinics are effective for patients with prostate Cancer. J Patient Exp. 2017;4(3):114\u201320.","journal-title":"J Patient Exp"},{"issue":"2","key":"5899_CR47","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5737\/1181912x1826468","volume":"18","author":"A Overend","year":"2008","unstructured":"Overend A, Khoo K, Delorme M, Krause V, Avanessian A, Saltman D. Evaluation of a nurse-led telephone follow-up clinic for patients with indolent and chronic hematological malignancies: a pilot study. Can Oncol Nurs J. 2008;18(2):64\u201373.","journal-title":"Can Oncol Nurs J"},{"issue":"1","key":"5899_CR48","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1186\/s12885-015-1815-7","volume":"15","author":"G Compaci","year":"2015","unstructured":"Compaci G, Rueter M, Lamy S, Oberic L, Recher C, Lapeyre-Mestre M, et al. Ambulatory medical assistance - after Cancer (AMA-AC): a model for an early trajectory survivorship survey of lymphoma patients treated with anthracycline-based chemotherapy. BMC Cancer. 2015;15(1):781.","journal-title":"BMC Cancer"},{"issue":"1","key":"5899_CR49","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1472-6963-12-220","volume":"12","author":"C Sanders","year":"2012","unstructured":"Sanders C, Rogers A, Bowen R, Bower P, Hirani S, Cartwright M, et al. Exploring barriers to participation and adoption of telehealth and telecare within the whole system demonstrator trial: a qualitative study. BMC Health Serv Res. 2012;12(1):220.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"5899_CR50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13063-015-0773-3","volume":"16","author":"A Foster","year":"2015","unstructured":"Foster A, Horspool KA, Edwards L, Thomas CL, Salisbury C, Montgomery AA, et al. Who does not participate in telehealth trials and why? A cross-sectional survey. Trials. 2015;16(1):50.","journal-title":"Trials."},{"issue":"1","key":"5899_CR51","first-page":"52","volume":"5","author":"M Elfil","year":"2017","unstructured":"Elfil M, Negida A. Sampling methods in clinical research; an educational review. Emergency. 2017;5(1):52.","journal-title":"Emergency."},{"issue":"1","key":"5899_CR52","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1471-2288-13-104","volume":"13","author":"SA Billingham","year":"2013","unstructured":"Billingham SA, Whitehead AL, Julious SA. An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom clinical research network database. BMC Med Res Methodol. 2013;13(1):104.","journal-title":"BMC Med Res Methodol"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05899-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-020-05899-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05899-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T02:05:01Z","timestamp":1605578701000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-020-05899-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5899"],"URL":"https:\/\/doi.org\/10.1186\/s12913-020-05899-8","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]},"assertion":[{"value":"25 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the National Data Protection Agency (jour. no. 2008-58-0028). An assessment by the Health Ethics Committee of the North Denmark Region deemed the study to be focused on quality improvement; therefore, it was exempted from formal ethical approval, according to Danish legislation. All patients provided written signed consent before entering the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors report no competing interests related to the research presented in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1047"}}